Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,475,445
+$55,489 QoQ
Shares Held
9,747
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#2,168
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026D'Orazio & Associates, Inc. holds $10,937,903 across 10 Drug Manufacturers - General names. JNJ ranks #1 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
9,747 | $2,475,445 | |
| 2 | LLY |
ELI LILLY & Co
|
2,049 | $2,457,632 | |
| 3 | ABBV |
AbbVie Inc.
|
5,514 | $1,387,542 | |
| 4 | AMGN |
Amgen Inc
|
3,096 | $1,121,123 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
7,176 | $906,615 | |
| 6 | NVS |
Novartis AG
|
4,370 | $684,866 | |
| 7 | PFE |
Pfizer Inc
|
24,083 | $579,918 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,050 | $520,425 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,475,445 | 9,747 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,419,956 | 9,900 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,049,011 | 9,901 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,671,561 | 9,015 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,492,367 | 9,770 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,536,839 | 9,267 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $868,443 | 6,005 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,183,524 | 7,303 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $837,496 | 5,730 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,022,065 | 6,461 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,039,499 | 6,632 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,099,127 | 7,057 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,296,518 | 7,833 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $919,770 | 5,934 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,177,387 | 12,326 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,932,385 | 11,829 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,541,141 | 8,682 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,359,885 | 7,673 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,125,298 | 6,578 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,050,719 | 6,506 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $952,361 | 5,781 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $934,822 | 5,688 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $919,256 | 5,841 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $846,829 | 5,688 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $799,762 | 5,687 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $837,396 | 6,386 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||